MMP-11 promoted the oral cancer migration and FAK/Src activation

Chung-Han Hsin; Ying-Erh Chou; Shun-Fa Yang; Shih-Chi Su; Yi-Ting Chuang; Shu-Hui Lin; Chiao-Wen Lin

doi:10.18632/oncotarget.15824

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

MMP-11 promoted the oral cancer migration and FAK/Src activation

Chung-Han Hsin, Ying-Erh Chou, Shun-Fa Yang, Shih-Chi Su, Yi-Ting Chuang, Shu-Hui Lin and Chiao-Wen Lin _

PDF | HTML | How to cite

Oncotarget. 2017; 8:32783-32793. https://doi.org/10.18632/oncotarget.15824

Metrics: PDF 1759 views | HTML 2904 views | ?

Abstract

Chung-Han Hsin1,2, Ying-Erh Chou1,3, Shun-Fa Yang3,4, Shih-Chi Su5, Yi-Ting Chuang4, Shu-Hui Lin4,6 and Chiao-Wen Lin7,8

1School of Medicine, Chung Shan Medical University, Taichung, Taiwan

2Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan

3Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

4Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

5Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan

6Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan

7Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan

8Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan

Correspondence to:

Chiao-Wen Lin, email: [email protected]

Keywords: matrix metalloproteinase, oral squamous cell carcinoma, metastasis, survival, FAK/Src pathway

Received: November 16, 2016 Accepted: February 08, 2017 Published: March 02, 2017

ABSTRACT

Matrix metalloproteinase-11 (MMP-11) has been observed in most invasive human carcinomas. The current study investigated the association between the clinicopathological characteristics and MMP-11 expression in oral squamous cell carcinoma (OSCC) patients. Immunohistochemistry (IHC) staining was performed to assess MMP-11 expression in 279 patients with OSCC. In addition, the metastatic effects of the MMP-11 overexpression on the OSCC cells were also investigated. We found that MMP-11 expression was present in 118/279 (42.3%) cases and expression of MMP-11 was associated with higher incidence of lymph node metastasis and worse grade of tumor differentiation. Importantly, OSCC patients with strong expression of MMP-11 had a significantly lower survival rate (p=0.010). Furthermore, MMP-11 overexpression in OSCC cells increased in vitro cell migration. Mechanistically, MMP-11 increased the cell motility of OSCC cells through focal adhesion kinase/Src kinase (FAK/Src) pathway. In conclusion, our results revealed that the MMP-11 expression in OSCC samples can predict the progression, especially lymph node metastasis, and the survival of OSCC patients in Taiwan.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15824

Publication Alerts

Research Papers:

MMP-11 promoted the oral cancer migration and FAK/Src activation

Abstract